You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of a novel highly effective influenza vaccine

    SBC: FLUGEN INC            Topic: NIAID

    DESCRIPTION provided by applicant Seasonal influenza flu virus an NIAID category C priority pathogen causes widespread infection resulting in at least million cases of severe illness and deaths worldwide Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or death from influenza Newly emerging strains can result ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. STTR Phase I: 24x7 mobile wireless monitoring of patient's vitals to proactively manage disease recovery

    SBC: Argosy Omnimedia, Inc.            Topic: SH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is found in the proposed technology development that facilitates direct, ubiquitous acquisition of key biomedical data, with little or no human intervention or introduction of errors, has the potential to reduce the costs of healthcare and to revolutionize healthcare delivery throughout our so ...

    STTR Phase I 2014 National Science Foundation
  4. STTR Phase I: Self-Inflating bubble provides comfortable, effective hearing protection with directionality

    SBC: ASIUS TECHNOLOGIES, LLC            Topic: BM

    The broader impact/commercial potential of this project will be to improve HPD use-rates among workers in loud noise environments, reduce permanent hearing loss rates and usher in the field of sealed-ear bio-acoustical studies. This HPD is expected to provide greater comfort and fit than custom earplugs yet have a cost similar to the annual expense of the foam type. The use-rate with this HPD is e ...

    STTR Phase I 2014 National Science Foundation
  5. STTR Phase I: Ferrofluidic enclosures for enhanced control of thermal and magnetic fields in spin-stabilized atomic micro-devices

    SBC: COMMET LLC            Topic: EW

    The broader impact/commercial potential of this project is determined by new consumer products and new industries which would flourish on portable and reliable atomic clocks, gyroscopes, and magnetometers when they become available. Proposed compact thermal and magnetic enclosure reduces the most bulky part of such devices and provides an avenue for further miniaturization. A chip-scale atomic clo ...

    STTR Phase I 2014 National Science Foundation
  6. Auto-antibody profiling of non-small cell lung cancer

    SBC: 20 20 Genesystems Inc            Topic: N/A

    DESCRIPTION (provided by applicant): Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically dismal outcomes. Circulating antibodies, generated to a wide range of tumor-associated proteins, can be translated into a valuable blood test for lung cancer. Preliminary data supports this hypothesis. ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  7. Oral Formulation of Zonulin Antagonist AT-1001 for Diabe

    SBC: ALBA THERAPEUTICS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): The trigger for autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D) is unclear. Evidence exists for the role of increased intestinal permeability, secondary to intestinal tight junctions (tj) disassembly, in the pathogenesis of various autoimmune diseases including T1 D. Over the last decade our studies have focused on the mechanism(s) of a ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  8. STTR Phase I: Ultrafast Response Transient Voltage Surge Suppressors

    SBC: ALD NANOSOLUTIONS, INC            Topic: EL

    This Small Business Technology Transfer (STTR) Phase I project supports the development of ultra-fast (< 1 ns) response Transient Voltage Surge Suppression (TVSS) devices to protect the power infrastructure. Fine nickel particle (~ 50-150 micrometer) samples will be nano-coated by Atomic Layer Deposition (ALD) with alumina (Al2O3) (10, 7.5, 5, 2.5, and 1.5 nm thick Al2O3 coating), providing novel ...

    STTR Phase I 2006 National Science Foundation
  9. STTR Phase I: Atomic Layer Deposition-Enabled Polymer Packaging for Integrating MEMS and Electronics

    SBC: ALD NANOSOLUTIONS, INC            Topic: EL

    This Small Business Technology Transfer (STTR) Phase I project will demonstrate a new nano-scale, conformal, atomic layer deposition (ALD)-enabled hermetic capping. Such an innovative capping technology will transform MEMS and electronics integration from dual-in-line packages (DIP) into chip-scale packages (CSP), wafer level packages (WLP) and three-dimensional (3-D) packages, which are required ...

    STTR Phase I 2006 National Science Foundation
  10. STTR Phase I: Fabrication of Coaxial Nanowires/Nanocables Using Carbon Nanotubes

    SBC: ALD NANOSOLUTIONS, INC            Topic: EL

    This Small Business Technology Transfer (STTR) Phase I project provides for the commercialization of composite alumina/tungsten/alumina (Al2O3/W/Al2O3) trilayers deposited by Atomic Layer Deposition (ALD) on carbon nanotubes (CNTs) to form coaxial nanowires/nanocables for nanoelectronic applications. Such coaxial nanostructures can be fabricated by first coating CNTs with a conformal and pinhole- ...

    STTR Phase I 2006 National Science Foundation
US Flag An Official Website of the United States Government